1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > IMS Country Review 2016: Sweden

IMS Country Review 2016: Sweden

  • July 2016
  • -
  • IMS Health
  • -
  • 81 pages

IMS Country Review™ 2016 provides comprehensive qualitative insights into a specific pharmaceutical market as well as showing sales trends over the last 5 years. Sales performance is analysed in terms of major corporations, therapeutic classes, major products and new product activity.

Table Of Contents

IMS Country Review 2016: Sweden
Table of Contents
SECTION 1: SYNOPSIS OF THE HEALTHCARE MARKET 5
MARKET TRENDS 5
HEALTHCARE PROVISION 5
PRESCRIBING POLICY 6
PRICING SYSTEM 7
REGULATORY ENVIRONMENT 8
INDUSTRY ENVIRONMENT 9
CHANNELS OF DISTRIBUTION 10
SWEDEN DATA COLLECTION 11
SECTION 2: COUNTRY SALES PERFORMANCE AND TRENDS 12
FIGURE 1: COUNTRY RANKING AMONGST 30 MARKETS WORLDWIDE 12
FIGURE 2: AUDITED MARKET TREND 13
FIGURE 3: LEADING 35 LOCAL COMPANIES 14
FIGURE 4: LEADING 35 CORPORATIONS 16
FIGURE 5: MARKET SHARE BY CORPORATE NATIONALITY 18
FIGURE 6: LEADING 15 THERAPEUTIC CLASSES (LEVEL 3) 2015 19
FIGURE 7: 15 FASTEST-GROWING THERAPEUTIC CLASSES (LEVEL 3) 2015 20
FIGURE 8-22: LEADING 15 THERAPEUTIC CLASS PROFILES 21
FIGURE 8: A10C HUMAN INSULIN+ANALOGUES 21
FIGURE 9: B1F DIRECT FACTOR XA INHIBS 22
FIGURE 10: B2D BLOOD COAGULATION 23
FIGURE 11: D5B SYST ANTIPSORIASIS PRDS 24
FIGURE 12: J1P OTH B-LACTAM EX PEN,CEPH 25
FIGURE 13: J5B ANTIVIRALS EXCL ANTI-HIV 26
FIGURE 14: J5C HIV ANTIVIRALS 27
FIGURE 15: L1G MAB ANTINEOPLASTICS 28
FIGURE 16: L1H PROTEIN KINASE INH A-NEO 29
FIGURE 17: L2B CYTO HORMONE ANTAGONISTS 30
FIGURE 18: L4B ANTI-TNF PRODUCTS 31
FIGURE 19: L4X OTHER IMMUNOSUPPRESSANTS 32
FIGURE 20: N2B NON-NARCOTIC ANALGESICS 33
FIGURE 21: N3A ANTI-EPILEPTICS 34
FIGURE 22: N7X ALL OTHER CNS DRUGS 35
FIGURE 23: LEADING 40 PRODUCTS 36
FIGURE 24: LEADING 40 NEW PRODUCTS 38
FIGURE 25: LEADING 15 PRODUCT FORMS 41
FIGURE 26: FASTEST GROWING 40 PRODUCTS SALES TRENDS 42
SECTION 3: APPENDICES 44
APPENDIX 1: AUDITED UNIVERSE 44
APPENDIX 2: COUNTRY SPECIFIC ALERTS 45
APPENDIX 3: MEASURE INDEX 48
APPENDIX 4: SALES DATA MEASURES 50
APPENDIX 5: *LATEST FACTORS 52
APPENDIX 6: QUARTERLY US$ EXCHANGE RATES BY COUNTRY 56
APPENDIX 7: CORPORATIONS 58
APPENDIX 8: PRODUCT NAMES 59
APPENDIX 9: THERAPIES 61
APPENDIX 10: EPHMRA ANATOMICAL THERAPEUTIC CLASSIFICATION 62

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.